Coll Plant Biotechnologies Ltd - Understand $clgn stock

$CLGN Market Cap: $46.49 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$650.0K

TTM

Gross Margin

-1857.48%

TTM

Net Earnings

-$17.42M

TTM

Current Assets

$16.50M

Q3 2024

Current Liabilities

$3.069M

Q3 2024

Current Ratio

537.54%

Q3 2024

Total Assets

$22.44M

Q3 2024

Total Liabilities

$5.524M

Q3 2024

Book Value

$16.92M

Q3 2024

Cash

$15.37M

Q3 2024

P/E

-2.669

Nov 29, 2024 EST

Free Cash Flow

-$13.63M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018
Revenue	$10.96M	$299.0K	$15.64M	$6.140M	$2.320M	$5.014M
YoY Change	3565.22%	-98.09%	154.74%	164.66%	-53.73%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018
Revenue	$10.96M	$299.0K	$15.64M	$6.140M	$2.320M	$5.014M
Cost Of Revenue	$1.125M	$400.0K	$1.638M	$3.000M	$1.880M	$1.659M
Gross Profit	$9.834M	-$101.0K	$14.00M	$3.140M	$440.0K	$3.355M
Gross Profit Margin	89.73%	-33.78%	89.53%	51.14%	18.97%	66.91%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018
Selling, General & Admin	$5.996M	$6.741M	$5.940M	$4.620M	$3.620M	$3.700M
YoY Change	-11.05%	13.48%	28.57%	27.62%	-2.16%
% of Gross Profit	60.97%		42.42%	147.13%	822.73%	110.28%
Research & Development	$10.48M	$10.26M	$7.631M	$3.660M	$4.090M	$3.984M
YoY Change	2.23%	34.39%	108.5%	-10.51%	2.66%
% of Gross Profit	106.61%		54.5%	116.56%	929.55%	118.75%
Depreciation & Amortization	$1.102M	$1.076M	$773.0K	$660.0K	$540.0K	$342.0K
YoY Change	2.42%	39.2%	17.12%	22.22%	57.89%
% of Gross Profit	11.21%		5.52%	21.02%	122.73%	10.19%
Operating Expenses	$16.48M	$10.26M	$13.57M	$8.740M	$8.070M	$7.600M
YoY Change	60.7%	-24.43%	55.27%	8.3%	6.18%
Operating Profit	-$6.646M	-$17.10M	$432.0K	-$5.600M	-$7.630M	-$4.245M
YoY Change	-61.13%	-4057.64%	-107.71%	-26.61%	79.74%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018
Interest Expense	$503.0K	$182.0K	$202.0K	-$140.0K	-$3.470M	-$1.987M
YoY Change	176.37%	-9.9%	-244.29%	-95.97%	74.64%
% of Operating Profit			46.76%
Other Income/Expense, Net	-$10.00K	$172.0K	-$30.00K	-$30.00K	-$60.00K	-$17.00K
YoY Change	-105.81%	-673.33%	0.0%	-50.0%	252.94%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018
Pretax Income	-$7.019M	-$16.93M	$237.0K	-$5.770M	-$11.16M	-$6.249M
YoY Change	-58.53%	-7241.35%	-104.11%	-48.3%	78.59%
Income Tax	$59.99M
% Of Pretax Income
Net Earnings	-$7.019M	-$16.93M	$237.0K	-$5.770M	-$11.16M	-$6.249M
YoY Change	-58.53%	-7241.35%	-104.11%	-48.3%	78.59%
Net Earnings / Revenue	-64.05%	-5660.54%	1.52%	-93.97%	-481.03%	-124.63%
Basic Earnings Per Share	-$0.62	-$1.53	$0.02	-$0.84
Diluted Earnings Per Share	-$0.62	-$1.53	$19.80K	-$837.4K	-$2.228M	-$1.425M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018
Cash & Short-Term Investments	$26.67M	$29.65M	$43.30M	$3.330M	$3.790M	$5.354M
YoY Change	-10.05%	-31.52%	1200.27%	-12.14%	-29.21%
Cash & Equivalents	$26.67M	$29.65M	$13.15M	$3.330M	$3.790M	$5.354M
Short-Term Investments
Other Short-Term Assets	$241.0K	$23.00K	$13.00K	$10.00K	$10.00K	$154.0K
YoY Change	947.83%	76.92%	30.0%	0.0%	-93.51%
Inventory	$714.0K	$1.430M	$1.081M	$1.260M	$890.0K	$814.0K
Prepaid Expenses
Receivables	$0.00	$9.000K	$270.0K	$830.0K	$80.00K	$516.0K
Other Receivables	$393.0K	$543.0K	$424.0K	$240.0K	$270.0K	$334.0K
Total Short-Term Assets	$28.02M	$31.66M	$45.09M	$5.680M	$5.040M	$7.172M
YoY Change	-11.49%	-29.78%	693.79%	12.7%	-29.73%
Property, Plant & Equipment	$5.859M	$5.677M	$5.681M	$4.900M	$5.540M	$1.407M
YoY Change	3.21%	-0.07%	15.94%	-11.55%	293.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$57.00K	$188.0K	$213.0K	$180.0K	$170.0K	$155.0K
YoY Change	-69.68%	-11.74%	18.33%	5.88%	9.68%
Total Long-Term Assets	$6.104M	$6.110M	$6.137M	$5.160M	$5.710M	$1.580M
YoY Change	-0.1%	-0.44%	18.93%	-9.63%	261.39%
Total Assets	$34.13M	$37.77M	$51.22M	$10.84M	$10.75M	$8.752M
YoY Change
Accounts Payable	$980.0K	$1.133M	$1.034M	$800.0K	$830.0K	$622.0K
YoY Change	-13.5%	9.57%	29.25%	-3.61%	33.44%
Accrued Expenses	$2.271M	$1.972M	$1.948M	$440.0K	$460.0K	$0.00
YoY Change	15.16%	1.23%	342.73%	-4.35%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$20.00K	$22.00K
YoY Change				-100.0%	-9.09%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.251M	$3.105M	$3.014M	$3.390M	$3.460M	$2.233M
YoY Change	4.7%	3.02%	-11.09%	-2.02%	54.95%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$22.00K
YoY Change					-100.0%
Other Long-Term Liabilities	$2.535M	$2.382M	$3.089M	$2.980M	$3.210M	$1.077M
YoY Change	6.42%	-22.89%	3.66%	-7.17%	198.05%
Total Long-Term Liabilities	$2.535M	$2.382M	$3.089M	$2.980M	$3.210M	$1.099M
YoY Change	6.42%	-22.89%	3.66%	-7.17%	192.08%
Total Liabilities	$5.786M	$5.487M	$6.103M	$6.360M	$6.660M	$3.332M
YoY Change	5.45%	-10.09%	-4.04%	-4.5%	99.88%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020
Basic Shares Outstanding	11.39M shares	11.03M shares	9.969M shares	6.887M shares
Diluted Shares Outstanding	11.39M shares	11.03M shares	11.97M shares	6.887M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $46.487 Million

About CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies Peers: Enlivex Therapeutics Ltd. Protalix BioTherapeutics, Inc. Evogene Ltd. Gamida Cell Ltd. UroGen Pharma Ltd.